Filing Details

Accession Number:
0001683168-19-002124
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-05 16:13:51
Reporting Period:
2019-05-29
Accepted Time:
2019-07-05 16:13:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1516079 Us-China Biomedical Technology Inc. UCBB Services-Advertising Agencies (7311) 274479356
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1713489 Qingxi Huang 21F, Hualing Building
111 Furong Rd, Changsha
Hunan Province, China F4 410000
Ceo, Cfo, Secy., Treas. Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-29 4,290,000 $214,500.00 12,422,000 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2019-05-29 10,725,000 $0.05 10,725,000 $0.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,725,000 2019-05-24 2020-11-24 No 4 P Indirect
Footnotes
  1. On May 29, 2019, China Israel Biotechnology Co. Ltd. ("CIB"), a Chinese corporation, of which Mr. Huang is a controlling officer and director of, acquired 4,290,000 units at purchase price of $0.05 per share. Each single Unit consists of one (1) share of common stock of the Company and two and one half (2.5) warrants (collectively the "Units"), which shall be exercisable for 18 months at $0.05 per share (the "Warrants").
  2. Mr. Huangs beneficial ownership includes 10,922,000 shares held by CIB and 1,500,000 shares held by Central Bio-MD Valley Technology Co., Ltd. ("CBV"), a Chinese corporation. Mr. Huang is a controlling officer and director of CIB and CBV and has voting and dispositive control over the shares.